Trial to Assess the Ocular Safety of Vorapaxar (SCH 530348) in Participants With Atherosclerosis (Study P05183)


Phase 3 Results

Summary of Purpose

This study is designed to evaluate the long-term ocular safety of SCH 530348 (vorapaxar) in participants with established atherosclerotic disease who are enrolled into the TRA 2°P - TIMI 50 Study (P04737) (NCT00526474).

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 23 June 2015.

1 Jul 2008 4 Feb 2008 1 Oct 2010 1 Oct 2010 1 Jun 2015 9 May 2014
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Investigator, Outcomes Assessor)
  • Purpose: Prevention
  • Endpoint: Safety Study
  • Intervention: Parallel Assignment


Not available